| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | G88KCP51RE |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 1 | D020522 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 267227-08-7 |
| ChEMBL | CHEMBL2108252 |
| FDA SRS | G88KCP51RE |
CONTENTS